Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry W Herr

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Journal of Oncology Practice|July 2, 2013
Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancerBenjamin A Spencer, Russell B McBride, Dawn L Hershman, et al.
BJU International|July 5, 2012
Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomyEugene K Lee, Harry W Herr, Rian J Dickstein, et al.
BJU International|October 17, 2013
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopyPhilip H Kim, Ranjit Sukhu, Billy H Cordon, et al.
BJU International|February 16, 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapyMatthew G Kaag, Matthew I Milowsky, Guido Dalbagni, et al.
International Scholarly Research Notices|July 20, 2016
Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary ExperienceWassim M Bazzi, Ryan P Kopp, Timothy F Donahue, et al.
The Journal of Urology|December 20, 2011
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinomaJonathan L Silberstein, Nicholas E Power, Caroline Savage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladderGuido Dalbagni, Paul Russo, Joel Sheinfeld, et al.
The Journal of Urology|May 23, 2018
Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort StudyPatrick Mazza, George W Moran, Gen Li, et al.
The Journal of Urology|November 18, 2011
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomyBehfar Ehdaie, Alexandra Maschino, Shahrokh F Shariat, et al.
The Journal of Urology|June 16, 2010
Clinical outcomes of primary bladder carcinoma in situ in a contemporary seriesDaher C Chade, Shahrokh F Shariat, Guilherme Godoy, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Journal of Oncology Practice|July 2, 2013
Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancerBenjamin A Spencer, Russell B McBride, Dawn L Hershman, et al.
BJU International|July 5, 2012
Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomyEugene K Lee, Harry W Herr, Rian J Dickstein, et al.
BJU International|October 17, 2013
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopyPhilip H Kim, Ranjit Sukhu, Billy H Cordon, et al.
BJU International|February 16, 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapyMatthew G Kaag, Matthew I Milowsky, Guido Dalbagni, et al.
International Scholarly Research Notices|July 20, 2016
Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary ExperienceWassim M Bazzi, Ryan P Kopp, Timothy F Donahue, et al.
The Journal of Urology|December 20, 2011
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinomaJonathan L Silberstein, Nicholas E Power, Caroline Savage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladderGuido Dalbagni, Paul Russo, Joel Sheinfeld, et al.
The Journal of Urology|May 23, 2018
Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort StudyPatrick Mazza, George W Moran, Gen Li, et al.
The Journal of Urology|November 18, 2011
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomyBehfar Ehdaie, Alexandra Maschino, Shahrokh F Shariat, et al.
The Journal of Urology|June 16, 2010
Clinical outcomes of primary bladder carcinoma in situ in a contemporary seriesDaher C Chade, Shahrokh F Shariat, Guilherme Godoy, et al.
Pageof 23